comparemela.com

Latest Breaking News On - Sinopharm china national biotech group - Page 1 : comparemela.com

New monkeypox research paves way for domestic vaccine

Sinopharm vaccine approved to treat children, teenagers

Sinopharm vaccine approved to treat children, teenagers By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-20 07:30 Share CLOSE A medical worker injects a dose of COVID-19 vaccine to a local resident in Ruili, Southwest China s Yunnan province, April 1, 2021. [Photo/Xinhua] Sinopharm s COVID-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement. The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the COVID-19 pandemic.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.